Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- befree-2016 importedOn "2016-02-19" NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_assertion wasGeneratedBy ECO_0000203 NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_assertion wasDerivedFrom befree-2016 NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_assertion SIO_000772 21898529 NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_assertion evidence source_evidence_literature NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.
- NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_assertion description "[Therefore, we propose that CTA-specific immunotherapy for AML should preferentially target PRAME and/or should be combined with the application of demethylating agents opening the perspective for alternative targets like CTA SSX-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921891.RAUR4-hYgM17uXFrZqdnqDZ8stvmMqYj7Ah3g18KtxgwE130_provenance.